Results 11 to 20 of about 885,970 (344)
Seasonal influenza vaccine in immunocompromised persons
Human Vaccines & Immunotherapeutics, 2018 Immunocompromised persons are at high risk of complications from influenza infection. This population includes those with solid organ transplants, hematopoietic stem cell transplants, solid cancers and hematologic malignancy as well as those with ...
Mohammad Bosaeed, Deepali Kumar
doaj +2 more sources
Nature Network Boston, 2022 Currently, licensed seasonal influenza vaccines display variable vaccine effectiveness, and there remains a need for novel vaccine platforms capable of inducing broader responses against viral protein domains conserved among influenza subtypes.
Katherine V. Houser +74 more
semanticscholar +1 more source
Progress towards the Development of a Universal Influenza Vaccine
Viruses, 2022 Influenza viruses are responsible for millions of cases globally and significantly threaten public health. Since pandemic and zoonotic influenza viruses have emerged in the last 20 years and some of the viruses have resulted in high mortality in humans ...
Wen-Chien Wang +3 more
semanticscholar +1 more source
Vaccines, 2022 Vaccination to prevent influenza virus infection and to lessen its severity is recommended among healthcare workers (HCWs). Health professionals have a higher risk of exposure to viruses and could transmit the influenza virus to vulnerable patients who ...
Malik Sallam +17 more
semanticscholar +1 more source
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2021 Background Influenza infection causes considerable morbidity and mortality in patients with cardiovascular disease. We assessed the effects of the influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease. Methods
Siva H. Yedlapati +10 more
semanticscholar +1 more source
Influenza and Other Respiratory Viruses, 2021 Standard‐dose seasonal influenza vaccines often produce modest immunogenic responses in adults ≥65 years old. MF59 is intended to elicit a greater magnitude and increased breadth of immune response.
B. Coleman +3 more
semanticscholar +1 more source
Vaccines, 2022 Influenza is a vaccine preventable disease and vaccination remains the most effective method of controlling the morbidity and mortality of seasonal influenza, especially with respect to risk groups.
C. Trombetta +4 more
semanticscholar +1 more source
Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine
Vaccines, 2021 Influenza virus has significant viral diversity, both through antigenic drift and shift, which makes development of a vaccine challenging. Current influenza vaccines are updated yearly to include strains predicted to circulate in the upcoming influenza ...
Brianna L. Bullard, E. Weaver
semanticscholar +1 more source
Live attenuated influenza vaccine.
Current Topics in Microbiology and Immunology, 2020 Cold-adapted Ann Arbor based live attenuated influenza vaccine (LAIV) has been available in the USA since 2003. The vaccine is efficacious against influenza infection.
Hong Jin, K. Subbarao
semanticscholar +1 more source
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza
npj Vaccines, 2021 Recent approval of mRNA vaccines for emergency use against COVID-19 is likely to promote rapid development of mRNA-based vaccines targeting a wide range of infectious diseases.
Sudha Chivukula +29 more
semanticscholar +1 more source